Activity of sulfonium bisphosphonates on tumor cell lines

Yonghui Zhang, Michael P. Hudock, Kilannin Krysiak, Rong Cao, Kyle Bergan, Fenglin Yin, Annette Leon, Eric Oldfield

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

We investigated three series of sulfonium bisphosphonates for their activity in inhibiting the growth of three human tumor cell lines. The first series consisted of 6 cyclic sulfonium bisphosphonates, the most active species having an (average) IC50 of 89 μM. The second consisted of 10 phenylalkyl and phenylalkoxy bisphosphonates, the most active species having an IC50 of 18 μM. The third series consisted of 17 n-alkyl sulfonium bisphosphonates, the most active species having an IC50 of ∼240 nM. Three QSAR models showed that the experimental cell growth inhibition results could be well predicted. We also determined the structures of one sulfonium bisphosphonate bound to farnesyl diphosphate synthase, finding that it binds exclusively to the dimethylallyl diphosphate binding site. These results are of interest since they show that sulfonium bisphosphonates can have potent activity against a variety of tumor cell lines, the most active species having IC50 values much lower than conventional nitrogen-containing bisphosphonates.

Original languageEnglish
Pages (from-to)6067-6079
Number of pages13
JournalJournal of Medicinal Chemistry
Volume50
Issue number24
DOIs
StatePublished - Nov 29 2007
Externally publishedYes

Fingerprint Dive into the research topics of 'Activity of sulfonium bisphosphonates on tumor cell lines'. Together they form a unique fingerprint.

  • Cite this

    Zhang, Y., Hudock, M. P., Krysiak, K., Cao, R., Bergan, K., Yin, F., Leon, A., & Oldfield, E. (2007). Activity of sulfonium bisphosphonates on tumor cell lines. Journal of Medicinal Chemistry, 50(24), 6067-6079. https://doi.org/10.1021/jm700991k